In the framework of a multidisciplinary project, the CEA Fundamental Research Division, in collaboration with the CEA LETI et the CEA LITEN, develops novel approaches toward the characterization of viral particles in aerosol phase. In this context, we are seeking a research engineer specialized in fluid mechanics. Read the complete description.
The FAIMS interface has just been installed on our new Orbitrap Exploris 480. This new MS instrument will enlarge our analytical capabilities.
Delphine Pflieger is seeking a motivated student to perform a PhD starting in October 2021. Briefly, the project aims at better understanding the molecular dysfunctions at stake in the rare neurodegenerative disease called Huntington’s disease, which results in motor, cognitive and psychiatric symptoms. More specifically, we want to decipher how perturbations of histone modifications lead […]
Pour participer à son activité de R&D et de service à la communauté, l’équipe EDyP, localisée à Grenoble, recherche un/une ingénieur(e) d’Etudes en analyses protéomiques basées sur la spectrométrie de masse. Au sein de l’équipe EDyP (Exploration de la Dynamique des Protéomes, edyp.fr), vous mettrez en oeuvre un ensemble de techniques et méthodes analytiques et […]
We are very proud to announce the publication of the PepS microfluidic device in Analytical Chemistry
We are pleased and very proud to announce the publication of Proline in Bioinformatics. Feel free to try the software by downloading the zero installation version.
We are pleased to announce the release of ProteoRE 2.1, a user-oriented Galaxy-based instance, for the functional interpretation and exploration of proteomics data for biomedical research; This version now comprises 20 tools organized in 4 sections (data manipulation and visualization; add features/annotation; functional analysis; pathways analysis. All data sources have been updated. Three new tools […]
Identifying HBc nuclear regulatory functions Despite the existence of a preventive vaccine, chronic infections with Hepatitis B virus (HBV) remain a major health problem worldwide, and represent the first cause of liver cancer. Current clinically accepted antivirals treatments generally lead to a significant reduction of viremia in the blood of patients. However, the liver viral […]